Intellia Therapeutics Market Sentiment

SPY777.29−0.16%QQQ743.86−0.99%BTC/USD82,716.64+1.20%DIA518.08+0.38%GLD382.24−0.61%TLT77.97−0.01%

Premium

Intellia Therapeutics Inc

NTLANASDAQ

Trade with Public

$12.58

-0.49-3.75%

Last update: Oct 12, 7:47 PM

$12.55

-0.52-3.98%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Intellia Therapeutics Market Sentiment - Benzinga

Intellia Therapeutics Market Sentiment

Market sentiment signals for Intellia Therapeutics (NTLA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 40.5% short float

Options Flow▲ 0.30 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

29 analysts

Options Flow (P/C)

0.30

More calls — Bullish

977 calls · 295 puts

Avg Consensus PT

$25

+96.7%

Highest Price Target

$65

+417.9%

Cantor Fitzgerald

Lowest Price Target

-60.2%

JP Morgan

Short Interest

40.5%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 6, 2026	Barclays	Eliana Merle—	-36.3%	$8	Initiate	Underweight
Sep 9, 2026	Citizens	Silvan Turkcan—	+139.0%	$30 → $30	Maintained	Market Outperform
Sep 9, 2026	Wedbush	David Nierengarten—	+3.6%	$12 → $13	Maintained	Neutral
Sep 9, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+99.2%	$25 → $25	Maintained	Buy
Aug 25, 2026	Citizens	Silvan Turkcan—	+139.0%	$30 → $30	Maintained	Market Outperform
Aug 7, 2026	Evercore ISI Group	Jonathan Miller—	+91.2%	$16 → $24	Upgrade	In-Line→Outperform
Jul 16, 2026	Wolfe Research	Andy Chen—	-28.3%	$9	Downgrade	Peer Perform→Underperform
Jul 10, 2026	Wedbush	David Nierengarten—	+35.5%	$12 → $17	Maintained	Neutral
Jun 16, 2026	Canaccord Genuity	Whitney Ijem—	+290.4%	$49 → $49	Maintained	Buy
Jun 15, 2026	Citizens	Silvan Turkcan—	+139.0%	$30 → $30	Maintained	Market Outperform
Jun 15, 2026	Wedbush	David Nierengarten—	-4.4%	$12 → $12	Maintained	Neutral
Jun 15, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+99.2%	$25 → $25	Maintained	Buy
May 13, 2026	Bernstein	William Pickering—	+35.5%	$13 → $17	Maintained	Market Perform
May 13, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+99.2%	$30 → $25	Maintained	Buy
May 12, 2026	Canaccord Genuity	Whitney Ijem—	+290.4%	$58 → $49	Maintained	Buy
May 12, 2026	Wedbush	David Nierengarten—	-4.4%	$12 → $12	Maintained	Neutral
Apr 28, 2026	Canaccord Genuity	Whitney Ijem—	+362.2%	$48 → $58	Maintained	Buy
Apr 28, 2026	Goldman Sachs	Salveen Richter—	-28.3%	$8 → $9	Maintained	Sell
Apr 28, 2026	Morgan Stanley	Terence Flynn—	+19.5%	$11 → $15	Maintained	Equal-Weight
Apr 28, 2026	Citizens	Silvan Turkcan—	+139.0%	$28 → $30	Maintained	Market Outperform
Apr 27, 2026	Chardan Capital	Geulah Livshits—	+139.0%	$27 → $30	Maintained	Buy
Apr 27, 2026	Baird	Jack Allen —	+3.6%	$7 → $13	Maintained	Neutral
Mar 4, 2026	Jones Trading	Debanjana Chatterjee—	+131.1%	$29	Upgrade	Hold→Buy
Mar 3, 2026	Canaccord Genuity	Whitney Ijem—	+282.5%	$54 → $48	Maintained	Buy
Mar 3, 2026	Leerink Partners	Mani Foroohar—	+131.1%	$27 → $29	Maintained	Outperform